Since ASOs dosed into cerebrospinal fluid distribute broadly throughout the central nervous system, understanding the differences in activity and duration of action of APP ASOs between different CNS cell types would be essential for further enhancements in design and ultimate potency of APP ASOs for AD therapy in the future. Here, APP is linked to Alzheimer disease.